US Patent Issued to Biodesix on March 11 for "Compositions, methods and kits for diagnosis of lung cancer" (Washington, California Inventors)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,247,980, issued on March 11, was assigned to Biodesix Inc. (Boulder, Colo.).

"Compositions, methods and kits for diagnosis of lung cancer" was invented by Paul Edward Kearney (Seattle), Kenneth C. Fang (San Francisco), Xiao-Jun Li (Bellevue, Wash.), Clive Hayward (Seattle) and Douglas Spicer (Enumclaw, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. Also provided are compositions comprising these biomarker proteins and methods of using these biomarker ...